Half year results
Toumaz Limited (AIM: TMZ, ‘Toumaz’,’the Group’), a pioneer in low cost, ultra-low power wireless communications technology, announces its half results for the six months ended 30 June 2011.
Highlights
- Establishment of joint venture with California Capital Equity (“CCE”) to commercialise Sensium disposable digital plaster (‘Sensium Plaster’) in hospitals worldwide
- FDA approval of complete Sensium Plaster
- Initial launch in US hospitals planned for Q1 2012
- Telran and Xenif chips continue to gain traction in consumer electronics market
- Cash position of £3.4m at 30 June 2011
Professor Chris Toumazou, Chief Executive of Toumaz, commented,
“We have achieved a number of key milestones over the last six months, including the approval of the Sensium plaster and the successful launch and growing customer interest in our newest ultra-low power radio chips, Xenif and Telran.
“The establishment of the JV with Patrick Soon-Shiong’s CCE is a great endorsement of our technology and provides us with considerable opportunities in the wireless healthcare market, including the upcoming launch of the Sensium plaster in the US.”
Enquiries:
Toumaz Limited |
020 7355 0036 |
Chris Toumazou, Chief Executive Officer |
|
Patrick Stephansen, Chief Financial Officer |
|
FinnCap |
020 7600 1658 |
Charles Cunningham (Corporate Finance) |
|
Brian Patient (Corporate Broking) |
|
College Hill |
020 7457 2020 |
Adrian Duffield/Rozi Morris |
About Toumaz (www.toumazltd.com)
Toumaz is pioneering low cost, ultra-low power wireless technologies for a wide range of markets including medical monitoring and internet-connected consumer devices.
Targeting the healthcare market, Toumaz’s ultra-low power sensor platform, Sensium™, is a leader in real-time wireless monitoring of the body’s vital signs. Sensium™ has the potential to transform medical monitoring and reduce the cost of healthcare by wirelessly connecting individuals to healthcare providers – simply, affordably and unobtrusively. For healthcare professionals, this creates new opportunities for pro-active monitoring and improved quality of care. For patients, it delivers new opportunities for lifestyle-compatible personalised healthcare.
Toumaz also uses its expertise to design devices for wireless connectivity and internet-connected consumer products. Toumaz currently supplies multimedia/FM/DAB chips and complete modules to leaders in the digital radio market, such as PURE.
Toumaz is an AIM listed company (AIM: TMZ) with development centres in Oxford, UK and Taipei City, Taiwan.